Calton & Associates, Inc. Repligen Corp Transaction History

Calton & Associates, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$140.68 - $188.02 $153,200 - $204,753	-1,089 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$161.19 - $257.96 $29,658 - $47,464	-184 Reduced 14.45%	1,089 $204,000
Q4 2021 Jan 13, 2022	SELL	$247.59 - $304.47 $6,189 - $7,611	-25 Reduced 1.93%	1,273 $337,000
Q3 2021 Nov 05, 2021	BUY	$194.77 - $324.21 $7,790 - $12,968	40 Added 3.18%	1,298 $375,000
Q2 2021 Aug 11, 2021	SELL	$165.87 - $220.95 $6,468 - $8,617	-39 Reduced 3.01%	1,258 $251,000
Q1 2021 May 03, 2021	SELL	$180.37 - $226.26 $721 - $905	-4 Reduced 0.31%	1,297 $252,000
Q4 2020 Jan 25, 2021	SELL	$148.08 - $206.57 $25,321 - $35,323	-171 Reduced 11.62%	1,301 $249,000
Q3 2020 Oct 30, 2020	SELL	$122.51 - $158.27 $28,422 - $36,718	-232 Reduced 13.62%	1,472 $217,000
Q2 2020 Aug 10, 2020	BUY	$94.33 - $140.48 $160,738 - $239,377	1,704 New	1,704 $211,000
Q1 2020 Apr 30, 2020	SELL	$84.96 - $109.14 $286,994 - $368,674	-3,378 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$73.84 - $93.08 $3,248 - $4,095	44 Added 1.32%	3,378 $312,000
Q3 2019 Nov 07, 2019	BUY	$76.65 - $95.51 $255,551 - $318,430	3,334 New	3,334 $256,000

495

53.9M

420K

85.3K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.1B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.